Since the end of 2019, Translational Medicine Network has launched "My 2019" annual thinking sharing, which invites industry experts and practitioners to focus on cancer treatment, genetic testing, new drug research and development, precision medicine, clinical application and other fields, presenting you with a feast of thinking in 2019. In 2020, "My 2020" annual thinking sharing adapts to the needs of the times, comprehensively presents it in the form of video, conveys the views of big coffee, and listens to front-line voices. In 2021, "My 2021" Annual Thinking Sharing gathered many industry leaders, told annual stories, and discussed the challenges and opportunities of industrial development under the epidemic. This year, "My 2022" starts again, content creates value, transformation creates the future!
In 2022, the impact of the pandemic on our lives and work will continue, and all walks of life are exploring new development opportunities amid change. The biomedical industry is no exception, with both opportunities and challenges. For example, with the multiple promotion of policies, talents, technology and capital, innovation has become the main theme of the current development of the biomedical industry, and the previous traditional pharmaceutical model is facing great challenges; How to adapt to the development of innovation and social needs has become an important issue facing the entire industry. In vitro diagnostics, molecular diagnostics, vaccine research and development, new drug research and development and many other biomedical subdivisions have also undergone major changes, and a series of breakthroughs have been made. For the extraordinary year of 2022, how do industry experts and practitioners feel? Let's hear it together!
CN